Literature DB >> 18664389

Brucella: a Mr "Hide" converted into Dr Jekyll.

Jean-Pierre Gorvel1.   

Abstract

Dr David Bruce (1855-1931) first identified the causative agent of brucellosis as a small Gram-negative alpha-Proteobacterium, which was later on called Brucella melitensis in his honor by Meyer and Shaw. Nowadays, four strains exhibit pathogenicity in humans with B. melitensis being the least host specific and also the most infectious for humans. The other strains are Brucella suis and Brucella abortus and more recently human cases being infected with Brucella cetaceae have been reported. Why such a reemerging disease is so difficult to fight, evidence shows that the pathogenic bacterium has developed strategies to hide from immune recognition.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18664389     DOI: 10.1016/j.micinf.2008.07.007

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  27 in total

1.  In search of Brucella abortus type IV secretion substrates: screening and identification of four proteins translocated into host cells through VirB system.

Authors:  María Inés Marchesini; Claudia K Herrmann; Suzana P Salcedo; Jean-Pierre Gorvel; Diego J Comerci
Journal:  Cell Microbiol       Date:  2011-06-24       Impact factor: 3.715

2.  Brucella arteritis: clinical manifestations, treatment, and prognosis.

Authors:  Jesica A Herrick; Robert J Lederman; Brigit Sullivan; John H Powers; Tara N Palmore
Journal:  Lancet Infect Dis       Date:  2014-01-28       Impact factor: 25.071

3.  Crystallographic and kinetic study of riboflavin synthase from Brucella abortus, a chemotherapeutic target with an enhanced intrinsic flexibility.

Authors:  María I Serer; Hernán R Bonomi; Beatriz G Guimarães; Rolando C Rossi; Fernando A Goldbaum; Sebastián Klinke
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2014-04-30

4.  Protective live oral brucellosis vaccines stimulate Th1 and th17 cell responses.

Authors:  Beata Clapp; Jerod A Skyberg; Xinghong Yang; Theresa Thornburg; Nancy Walters; David W Pascual
Journal:  Infect Immun       Date:  2011-07-18       Impact factor: 3.441

5.  Course of infection with the emergent pathogen Brucella microti in immunocompromised mice.

Authors:  María P Jiménez de Bagüés; Alba de Martino; Juan F Quintana; Ana Alcaraz; Julián Pardo
Journal:  Infect Immun       Date:  2011-08-08       Impact factor: 3.441

6.  Acute brucellosis associated with isolated splenic and left gastric artery vasculitis and acute ischemic bowel infarction. A systematic review of the most recent cases.

Authors:  Mariam Ahmed Saad; Eiman Saeed Ahmed; Fahad Ali Alghamdi; Yasser Ragab Fahmy; Yasser Emadeldeen Amin; Ahmed Ahmed Saad
Journal:  Infez Med       Date:  2021-09-10

7.  A rare case of seronegative culture--proven infection with Brucella suis.

Authors:  Kushal Naha; Sowjanya Dasari; Vinay Pandit; Shubha Seshadri
Journal:  Australas Med J       Date:  2012-07-31

8.  BtaE, an adhesin that belongs to the trimeric autotransporter family, is required for full virulence and defines a specific adhesive pole of Brucella suis.

Authors:  Verónica Ruiz-Ranwez; Diana M Posadas; Charles Van der Henst; Silvia M Estein; Gastón M Arocena; Patricia L Abdian; Fernando A Martín; Rodrigo Sieira; Xavier De Bolle; Angeles Zorreguieta
Journal:  Infect Immun       Date:  2013-01-14       Impact factor: 3.441

9.  Use of S-[2,3-bispalmitoyiloxy-(2R)-propyl]-R-cysteinyl-amido-monomethoxy polyethylene glycol as an adjuvant improved protective immunity associated with a DNA vaccine encoding Cu,Zn superoxide dismutase of Brucella abortus in mice.

Authors:  Angello Retamal-Díaz; Roberto Riquelme-Neira; Darwin Sáez; Alejandra Rivera; Pablo Fernández; Alex Cabrera; Carlos A Guzmán; Angel Oñate
Journal:  Clin Vaccine Immunol       Date:  2014-08-27

10.  Yersinia enterocolitica serotype O:9 cultured from Swedish sheep showing serologically false-positive reactions for Brucella melitensis.

Authors:  Erika Chenais; Elisabeth Bagge; Susanne Thisted Lambertz; Karin Artursson
Journal:  Infect Ecol Epidemiol       Date:  2012-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.